EP1922072A4 - Melanocortin receptor-specific piperazine compounds with diamine groups - Google Patents

Melanocortin receptor-specific piperazine compounds with diamine groups

Info

Publication number
EP1922072A4
EP1922072A4 EP06813393A EP06813393A EP1922072A4 EP 1922072 A4 EP1922072 A4 EP 1922072A4 EP 06813393 A EP06813393 A EP 06813393A EP 06813393 A EP06813393 A EP 06813393A EP 1922072 A4 EP1922072 A4 EP 1922072A4
Authority
EP
European Patent Office
Prior art keywords
melanocortin receptor
piperazine compounds
diamine groups
specific piperazine
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06813393A
Other languages
German (de)
French (fr)
Other versions
EP1922072A2 (en
Inventor
Shubh D Sharma
Yi-Qun Shi
Kevin Burris
Zhijun Wu
Papireddy Purma
Yadi Reddy Bonuga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Palatin Technologies Inc
Original Assignee
Palatin Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palatin Technologies Inc filed Critical Palatin Technologies Inc
Publication of EP1922072A2 publication Critical patent/EP1922072A2/en
Publication of EP1922072A4 publication Critical patent/EP1922072A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
EP06813393A 2005-08-11 2006-08-11 Melanocortin receptor-specific piperazine compounds with diamine groups Withdrawn EP1922072A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70748805P 2005-08-11 2005-08-11
PCT/US2006/031472 WO2007021990A2 (en) 2005-08-11 2006-08-11 Melanocortin receptor-specific piperazine compounds with diamine groups

Publications (2)

Publication Number Publication Date
EP1922072A2 EP1922072A2 (en) 2008-05-21
EP1922072A4 true EP1922072A4 (en) 2010-12-29

Family

ID=37758229

Family Applications (2)

Application Number Title Priority Date Filing Date
EP06813393A Withdrawn EP1922072A4 (en) 2005-08-11 2006-08-11 Melanocortin receptor-specific piperazine compounds with diamine groups
EP06813394A Withdrawn EP1919479A4 (en) 2005-08-11 2006-08-11 Melanocortin receptor-specific piperazine and keto-piperazine compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP06813394A Withdrawn EP1919479A4 (en) 2005-08-11 2006-08-11 Melanocortin receptor-specific piperazine and keto-piperazine compounds

Country Status (4)

Country Link
EP (2) EP1922072A4 (en)
JP (2) JP2009504672A (en)
CN (2) CN101272788A (en)
WO (2) WO2007021991A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
EP1922072A4 (en) * 2005-08-11 2010-12-29 Palatin Technologies Inc Melanocortin receptor-specific piperazine compounds with diamine groups
WO2008090357A2 (en) * 2007-01-24 2008-07-31 Palatin Technologies, Inc. N, n; -substituted piperazines binding to melanocortin receptor
WO2009144432A1 (en) * 2008-05-30 2009-12-03 Palatin Technologies, Inc. Mc4-r agonists for the treatment of obesity
EP3381913B1 (en) * 2015-11-27 2021-03-31 Mitsubishi Tanabe Pharma Corporation 2-(((pyrrolidin-3-yl)carbonyl)amino)-1h-imidazole derivatives as melanocortin receptor 1 (mcr1) agonists for treating rheumatoid arthritis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157264A1 (en) * 2001-08-10 2004-08-12 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US20050130988A1 (en) * 2001-08-10 2005-06-16 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
AR043434A1 (en) * 2003-03-03 2005-07-27 Merck & Co Inc PIPERIZACINE DERIVATIVES ACILATED AS AGELISTS OF THE RECEIVER OF MELANOCORTINA-4. PHARMACEUTICAL COMPOSITIONS AND USES
EP1922072A4 (en) * 2005-08-11 2010-12-29 Palatin Technologies Inc Melanocortin receptor-specific piperazine compounds with diamine groups

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157264A1 (en) * 2001-08-10 2004-08-12 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US20050130988A1 (en) * 2001-08-10 2005-06-16 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule

Also Published As

Publication number Publication date
WO2007021991A3 (en) 2007-07-12
WO2007021991A2 (en) 2007-02-22
WO2007021990A3 (en) 2007-08-09
JP2009504672A (en) 2009-02-05
CN101272788A (en) 2008-09-24
EP1919479A2 (en) 2008-05-14
WO2007021990A2 (en) 2007-02-22
CN101272789A (en) 2008-09-24
EP1919479A4 (en) 2010-11-17
JP2009504671A (en) 2009-02-05
EP1922072A2 (en) 2008-05-21

Similar Documents

Publication Publication Date Title
HUS2100054I1 (en) Melanocortin receptor ligands
EP1872641A4 (en) Layered structure with printed elements
GB0519009D0 (en) Pocketted spring units
EP1835006A4 (en) Organic electroluminescence element
GB2424126B (en) Unit arrangement
IL187395A0 (en) Laminated felt articles
EP1881543A4 (en) Organic electroluminescent element
EP1848633A4 (en) Fuel supply systems having operational resistance
EP1944527A4 (en) Feeding unit
GB0520115D0 (en) Ink-less printing
AU309753S (en) Media case
EP1942006A4 (en) Printer
EP1922072A4 (en) Melanocortin receptor-specific piperazine compounds with diamine groups
TWI319962B (en) Ionizer with parts-extension unit
GB2432813B (en) Printer
EP1994209A4 (en) Small molecule printing
EP1941573A4 (en) Fuel supply systems having operational resistance
GB2428621B (en) Pinhead
GB0618962D0 (en) Printer
TWI369807B (en) Fuel supply systems having operational resistance
TWM291329U (en) Paint-dotting pen structure
GB0524468D0 (en) Spring units
PL372284A1 (en) Wooden-metallic structural element
GB0506820D0 (en) Saddles
GB0523373D0 (en) Nidogen/snep-like molecule

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080222

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1117062

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20101130

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 241/14 20060101ALI20101124BHEP

Ipc: A61P 15/10 20060101ALI20101124BHEP

Ipc: C07D 241/04 20060101ALI20101124BHEP

Ipc: A61K 31/496 20060101AFI20080318BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110301

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1117062

Country of ref document: HK